Boston Scientific recalls Taxus Express2 stents
Compliance Monitor, July 7, 2004
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Boston Scientific Corp. announced July 2 it will recall 200 of its recently approved drug-coated coronary stents because of a malfunction that resulted in at least one death.
The medical-equipment manufacturer said there are elements in the delivery catheters that have the potential to block balloon deflation during a coronary angioplasty procedure.
It blamed the problem on a manufacturing defect that has since been fixed.
Boston Scientific's Taxus Express2 stent is coated with slow-release drugs to prevent scar tissue from forming new blockages after surgery.
The stents were shipped to 99 U.S. hospitals.
The company said it reported one death and 16 serious injuries from such deflation failures to the Food and Drug Administration.
To read more, click here.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
Most Popular
- Articles
-
- PhRMA revises guidelines for clinical trials
- Peer Review Monthly: Amazing Grace
- Q/A: Appropriate use of code 96376
- Pressure-relieving mattresses for all New Jersey nursing homes
- Set the bar with outpatient coding productivity standards
- CMS releases updates to quality of life F-tags
- Transmittals and MLN Matters Articles
- Long-term care insurance plan could partially offset the cost of healthcare reform
- Complex reviews to arrive as soon as August
- Tip: Report non-compliance promptly
- E-mailed
-
- Peer Review Monthly: Amazing Grace
- Q/A: Appropriate use of code 96376
- Pressure-relieving mattresses for all New Jersey nursing homes
- Complex reviews to arrive as soon as August
- Note from Peggy
- Washington DC-area hospital targets CHF patients as starting point for preventing readmissions
- Don’t put patients in egress halls when ED overcrowds
- AMA adopts policy that makes quality care part of physicians’ ethical responsibilities
- Use a change-of-status form to ensure compliance when reporting condition code 44
- ED overcrowding may lead to increased chance of adverse outcomes for chest pain patients
- Searched
